Germany · Delayed Price · Currency is EUR SynBiotic SE Statistics
Total Valuation
SynBiotic SE has a market cap or net worth of EUR 11.24 million.
| Market Cap | 11.24M |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 6.82M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.91 |
| PB Ratio | 0.73 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of 0.27.
| Current Ratio | 0.81 |
| Quick Ratio | 0.33 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.41 |
| Interest Coverage | -43.09 |
Financial Efficiency
Return on equity (ROE) is -61.58% and return on invested capital (ROIC) is -22.02%.
| Return on Equity (ROE) | -61.58% |
| Return on Assets (ROA) | -13.92% |
| Return on Invested Capital (ROIC) | -22.02% |
| Return on Capital Employed (ROCE) | -31.27% |
| Weighted Average Cost of Capital (WACC) | 4.77% |
| Revenue Per Employee | 70,206 |
| Profits Per Employee | -193,284 |
| Employee Count | 55 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 0.76 |
Taxes
| Income Tax | -134,909 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.67% in the last 52 weeks. The beta is 0.17, so SynBiotic SE's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -42.67% |
| 50-Day Moving Average | 4.74 |
| 200-Day Moving Average | 6.58 |
| Relative Strength Index (RSI) | 39.50 |
| Average Volume (20 Days) | 250 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SynBiotic SE had revenue of EUR 3.86 million and -10.63 million in losses. Loss per share was -2.24.
| Revenue | 3.86M |
| Gross Profit | 1.51M |
| Operating Income | -8.41M |
| Pretax Income | -11.87M |
| Net Income | -10.63M |
| EBITDA | -7.54M |
| EBIT | -8.41M |
| Loss Per Share | -2.24 |
Balance Sheet
The company has 2.07 million in cash and 4.15 million in debt, with a net cash position of -2.08 million.
| Cash & Cash Equivalents | 2.07M |
| Total Debt | 4.15M |
| Net Cash | -2.08M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 15.33M |
| Book Value Per Share | 3.15 |
| Working Capital | -1.49M |
Cash Flow
In the last 12 months, operating cash flow was -2.92 million and capital expenditures -19,181, giving a free cash flow of -2.94 million.
| Operating Cash Flow | -2.92M |
| Capital Expenditures | -19,181 |
| Depreciation & Amortization | 868,079 |
| Net Borrowing | -222,676 |
| Free Cash Flow | -2.94M |
| FCF Per Share | n/a |
Margins
Gross margin is 39.01%, with operating and profit margins of -217.87% and -275.31%.
| Gross Margin | 39.01% |
| Operating Margin | -217.87% |
| Pretax Margin | -307.44% |
| Profit Margin | -275.31% |
| EBITDA Margin | -195.39% |
| EBIT Margin | -217.87% |
| FCF Margin | n/a |
Dividends & Yields
SynBiotic SE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,799.73% |
| Shareholder Yield | -1,799.73% |
| Earnings Yield | -94.58% |
| FCF Yield | -26.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for SynBiotic SE is 6.05, which is 171.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 6.05 |
| Price Target Difference | 171.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 70.24% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SynBiotic SE has an Altman Z-Score of -1.91 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.91 |
| Piotroski F-Score | 1 |